What are Zerbaxa’s annual sales (Zerbaxa = ceftolozane/tazobactam)?
Zerbaxa (ceftolozane/tazobactam) annual sales figures are not provided in the information available here, so I can’t state the exact sales amount for the relevant years.
How are Zerbaxa sales usually reported (and why you might not find one single number)?
Drug “sales” are typically reported as total sales across all markets for a given year, often in company financial statements. Zerbaxa is co-developed and marketed by Merck, and annual sales can appear in Merck’s quarterly and annual filings as product revenue (or within antimicrobial segments), which may be aggregated rather than shown as a standalone line item every period.
Which “Zerbaxa annual sales” number should you look for?
People searching this term usually want one of these:
- Sales for a specific calendar year (e.g., 2020 vs. 2021 vs. 2022)
- Sales for a specific quarter
- Global versus U.S.-only figures
- Revenue reported by a company (GAAP/IFRS reporting basis) versus estimates from market-research firms
If you tell me the year, I can narrow the answer
Share the year you mean (for example, “2023 annual sales”), and whether you want global sales or U.S. sales. With that, I can format the answer around the right reporting period and definition.
Sources
No sources were provided in the prompt, so there’s nothing I can cite for Zerbaxa annual sales.
No AI-generated response content or user claim was provided to evaluate against the supplied FDA-approved ZERBAXA prescribing information excerpts.